This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Amarantus To Evaluate LymPro Test As A Diagnostic And Prognostic For Chronic Traumatic Encephalopathy

Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis, today announced that it plans to evaluate its LymPro Test® as a potential diagnostic and prognostic for Chronic Traumatic Encephalopathy (CTE).

“The scientific basis of cell-cycle dysfunction that underpins the rationale for development of the LymPro Test as a diagnostic blood test for Alzheimer’s disease may also be utilized to diagnose CTE in populations that have been subjected to multiple head injuries and possibly even identify individuals who are pre-disposed to developing CTE before they engage in activities likely to subject them to multiple head injuries,” said Dr. John W. Commissiong, Chief Scientific Officer of Amarantus. “As a blood test, LymPro would have significant advantages over other more complex and expensive diagnostic alternatives, in particular the ability to detect the onset of CTE at an early stage. We plan to begin the evaluation process in the second half of 2013 by conducting a small proof-of-concept clinical study in addition to our planned Alzheimer’s studies.”

Amarantus is a co-host of the Concussion Awareness Summit (#C4CT Summit) being held today at the Minneapolis Club in Minnesota, bringing together current and former professional athletes, scientists, physicians and business leaders to discuss the effects of concussions, including CTE. Dr. Commissiong will be presenting the scientific rationale for the Company’s planned studies at the #C4CT Summit later today.

The potential market for a CTE diagnostic/prognostic is large and widespread. According to various surveys and studies, approximately 1.5 1 million Americans participate in contact sports at the collegiate and high school level, with another 3.5 2 million in youth sports leagues. It is estimated that at least 1.6 3 million athletes suffer a concussion each year in the United States; 1.7 million more Americans receive traumatic brain injury through accidents every year 4; and 274,000 members of the U.S. armed forces have suffered traumatic brain injury since 2000 5.

About Chronic Traumatic Encephalopathy

Chronic Traumatic Encephalopathy is a progressive degenerative disease of the brain found in athletes and others with a history of repetitive brain trauma. This trauma, which includes multiple concussions, triggers progressive degeneration of the brain tissue, including the build-up of an abnormal protein called tau. These changes in the brain can begin months, years or even decades after the last concussion or end of active athletic involvement. The brain degeneration is associated with memory loss, confusion, impaired judgment, paranoia, impulse control problems, aggression, depression and, eventually, progressive dementia.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs